)
)
Achilles Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Achilles Therapeutics plc
Access all reports
Achilles Therapeutics plc is a biopharmaceutical company based in the United Kingdom, focused on developing precision T cell therapies targeting cancer. Using its proprietary platform, Achilles designs therapies that target clonal neoantigens—unique markers on tumor cells—enabling a personalized approach to treatment. The company’s therapeutic programs are primarily aimed at treating solid tumors, including lung and melanoma cancers. The company is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
ACHL
Country
🇺🇸 United States